ArticleFrontiers in neurology2017

Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease.

Rosanna Squitti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.